Complete genome sequence of pseudomonas aeruginosa lytic bacteriophage PA1Ø which resembles temperate bacteriophage D3112

Journal of Virology

Volumn 86, Issue 6, 2012, Pages 3400-3401

  Kim, Shukho ^a   Rahman, Marzia ^a   Kim, Jungmin ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIOPHAGE; BACTERIOPHAGE PHI PA1; EVOLUTIONARY HOMOLOGY; GENE SEQUENCE; GENOME ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; VIRUS GENOME; VIRUS ISOLATION;

BASE SEQUENCE; GENOME, VIRAL; MOLECULAR SEQUENCE DATA; PHYLOGENY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PHAGES;

PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84863258111     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07191-11     Document Type: Article

References (15)

1. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW. 2011. GenBank. Nucleic Acids Res. 39:D32-D37.
2. Darzins A, Casadaban MJ. 1989. Mini-D3112 bacteriophage transposable elements for genetic analysis of Pseudomonas aeruginosa. J. Bacteriol. 171:3909 -3916.
3. Delcher AL, Bratke KA, Powers EC, Salzberg SL. 2007. Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics 23:673- 679.
4. Driscoll JA, Brody SL, Kollef MH. 2007. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67:351-368.
5. Gasteiger E, Jung E, Bairoch A. 2001. SWISS-PROT: connecting biomolecular knowledge via a protein database. Curr. Issues Mol. Biol. 3:47-55.
6. Govan JR, Brown AR, Jones AM. 2007. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol. 2:153-164.
7. Harper DR, Enright MC. 2011. Bacteriophages for the treatment of Pseudomonas aeruginosa infections. J. Appl. Microbiol. 111:1-7.
8. Hawkins C, Harper D, Burch D, Anggard E, Soothill J. 2010. Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial. Vet. Microbiol. 146:309 -313.
9. McGarvey PB, et al. 2000. PIR: a new resource for bioinformatics. Bioinformatics 16:290 -291.
10. Rhoads DD, et al. 2009. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J. Wound Care 18:237-238.
11. Roncero C, Darzins A, Casadaban MJ. 1990. Pseudomonas aeruginosa transposable bacteriophages D3112 and B3 require pili and surface growth for adsorption. J. Bacteriol. 172:1899 -1904.
12. Salmon KA, Freedman O, Ritchings BW, DuBow MS. 2000. Characterization of the lysogenic repressor (c) gene of the Pseudomonas aeruginosa transposable bacteriophage D3112. Virology 272:85-97.
13. Tatusov RL, Koonin EV, Lipman DJ. 1997. A genomic perspective on protein families. Science 278:631- 637.
14. Wang PW, Chu L, Guttman DS. 2004. Complete sequence and evolutionary genomic analysis of the Pseudomonas aeruginosa transposable bacteriophage D3112. J. Bacteriol. 186:400-410.
15. Yoon SS, et al. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3:593- 603.